We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix,  Inc

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
25 Feb 2021 - 27 Feb 2021

Radiosensitizer Molecule Enhances RT in Hypoxic Tumor Cores

By MedImaging International staff writers
Posted on 21 May 2019
Print article
Image: The novel nanoparticle enhances RT killing of cancer cells in the low-oxygen tumor core (Photo courtesy of Wenpei Fan, LOMIN Laboratory, NIBIB).
Image: The novel nanoparticle enhances RT killing of cancer cells in the low-oxygen tumor core (Photo courtesy of Wenpei Fan, LOMIN Laboratory, NIBIB).
A novel nanoparticle that generates radiation-induced reactive oxygen species (ROS) can dramatically increase the success of radiation therapy (RT), claims a new study.

Developed, among others, at the National Institute of Biomedical Imaging and Bioengineering (NIBIB; Bethesda, MD, USA), Zhejiang University (Hangzhou, China), the Chinese Academy of Sciences (Shenyang, China), the radiosensitizer molecule is made of hollow mesoporous organosilica nanoparticles (HMONs) that contain pores with a diameter of 2-50 nanometers. The HMONs are loaded with two different compounds; one creates ROS in an oxygen-rich environment when hit with radiation. The other creates ROS when hit with radiation in the hypoxic core of the tumor.

The loaded nanoparticles were tested in a human glioblastoma cell line, revealing that the combination of nanoparticles and radiation shredded the DNA of the glioblastoma cells, compared with nanoparticles alone or radiation alone. Tests showed that the nanoparticles generated extremely reactive oxygen free radicals by peroxy bond cleavage when exposed to radiation in both normoxic and hypoxic conditions, confirming that the system worked as designed. The study was published in the March 2019 edition of Nature Communications.

“When hit with radiation the particle produces destructive oxygen free radicals in normal and low oxygen parts of the tumor. Carbon monoxide gas, which is toxic to tumors, is further created when the oxygen free radicals interact with the compound FeCO,” said lead author Wenpei Fan, PhD, of the NIBIB Laboratory of Molecular Imaging and Nanomedicine (LOMIN). “We believe this therapy approach offers new possibilities for enhanced X-ray-activated treatment for future deep-cancer therapy. The next logical step is to optimize the structure and scale up nanoparticle synthesis to allow clinical translation of this type of radiotherapy enhancement.”

ROS are chemically reactive chemical species containing oxygen, such asperoxides, superoxide, hydroxyl radical, and singlet oxygen. In a biological context, ROS are formed as a natural byproduct of the normal metabolism of oxygen and have important roles in cell signaling and homeostasis. However, during times of environmental stress, such as ultraviolet (UV) or heat exposure, ROS levels can increase dramatically, resulting in oxidative stress and significant damage to cell structures.

Related Links:
National Institute of Biomedical Imaging and Bioengineering
Zhejiang University
Chinese Academy of Sciences

Print article


Industry News

view channel

New AI-Based Image Analysis Platform Enables Physicians to Analyze CT and MRI Scans in Half the Time of Traditional Methods

The US Food and Drug Administration (FDA) has granted 510(k) clearance for a new image analysis platform that enables physicians to analyze CT and MRI scans in half the time of traditional methods.... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.